Back to search
FDAFDA · Food and drugs·Recall number D-1486-2014

OXYCODONE HYDROCHLORIDE C II Oral Solution USP, 5 mg/5 mL, 15 mL Vial, Rx only. Boehringer Ingelheim, Roxane Laboratories. Roxane Laboratories, Inc. Columbus, Ohio 43216. NDC: 0054-0523-41.

Published August 6, 2014 · Recall initiated: July 28, 2014

Summary

FDA records drug Class III recall D-1486-2014, published August 6, 2014 and initiated July 28, 2014. Recalling firm: Boehringer Ingelheim Roxane Inc; Status: Terminated; Reported quantity: 2,149 Bottles; Lot: Lot #: 360241A, Expiry: 05/2015. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specifications: Out of specification result for preservative sodium benzoate.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Boehringer Ingelheim Roxane Inc
Distributor
U.S. Nationwide
Lot
Lot #: 360241A, Expiry: 05/2015.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was OXYCODONE HYDROCHLORIDE C II Oral Solution USP, 5 mg/5 mL, 15 mL Vial, Rx only. Boehringer Ingelheim, Roxane Laboratories. Roxane Laboratories, Inc. Columbus, Ohio 43216. NDC: 0054-0523-41. recalled?

Yes. FDA published recall D-1486-2014 on August 6, 2014. Reported hazard: Failed Stability Specifications: Out of specification result for preservative sodium benzoate.

What should I do if I have this product?

Voluntary: Firm initiated · Letter